Originally developed in the 1950s as a malaria treatment, hydralazine showed antihypertensive ability and was soon repurposed.[A186841] Hydralazine is a hydrazine derivative vasodilator used alone or as adjunct therapy in the treatment of hypertension and only as adjunct therapy in the treatment of heart failure.[A186820,L8782,L8785] Hydralazine is no longer a first line therapy for these indications since the development of newer antihypertensive medications.[T691] Hydralazine hydrochloride was FDA approved on 15 January 1953.[L8779]
Synonyms
Hydralazine
Hypophthalin
Hydrazone 1(2H)-phthalazinone
Hydrallazine
1-Hydrazinophthalazine
Idralazina
1-Phthalazinylhydrazine
Phthalazin-1-ylhydrazine
Hydrazinophthalazine
Hidralazina
Hydralazin
6-Hydralazine
Hydralazine hydrochloride
(1Z)-1(2H)-Phthalazinone hydrazone
(2H)-Phthalazinone hydrazone
Hydralazinum
Brand Names
Apresoline
Apresoline Tablets, 10mg
Ser-Ap-Es
Hydralazine Hydrocloride
Hydralazine HCl and Hydrochlorothiazide
HydrALAZINE Hydrochloride
Asn-hydralazine
Apresoline Tablets, 25mg
Novo-hylazin Tab 10mg USP
Hydralazine Hydrochloride Injection
Hydralazine-50 Tab
Nu-hydral Tab 10mg
Nu-hydral Tab 50 mg
Ser-AP-ES Tab
Apresoline hydrochloride
Jamp-hydralazine
Apo-hydralazine
Hydralazine HCl
Novo-hylazin Tab 50mg
PMS-hydralazine
Hydralazine-10 Tab 10mg
Hydralazine-25 Tab
BiDil
Hydralazine Hydrochloride
Apresoline Tablets, 50mg
Nu-hydral Tab 25mg
Isosorbide Dinitrate and Hydralazine Hydrochloride
HydrALAZINE hydrochloride
Isosorbide dinitrate and hydralazine hydrochloride
hydrALAZINE Hydrochloride
Hydralazine Hydrochloride Injection, USP
Hydralazine
Mint-hydralazine
Novo-hylazin Tab 25mg
Indication
Hydralazine is indicated alone or adjunct to standard therapy to treat essential hypertension.[L8782] A combination product with isosorbide dinitrate is indicated as an adjunct therapy in the treatment of heart failure.[L8785]
Categories
Antihypertensive Agents
Antihypertensive Agents Indicated for Hypertension
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682